Simplify
Health
Care
ETF
Schedule
of
Investments
March
31,
2024
(Unaudited)
1
Shares
Value
Common
Stocks
–
98.1%
Health
Care
–
91.3%
Abbott
Laboratories
........................................................
8,467
$
962,359
AbbVie,
Inc.
..............................................................
19,045
3,468,094
Akero
Therapeutics,
Inc.*
...................................................
33,199
838,607
Align
Technology,
Inc.*
.....................................................
19,251
6,312,788
Avantor
Inc*
..............................................................
109,781
2,807,100
Bio-Techne
Corp.
.........................................................
9,152
644,209
Boston
Scientific
Corp.*
....................................................
62,458
4,277,748
Bristol-Myers
Squibb
Co.
...................................................
530
28,742
Cigna
Group
(The)
........................................................
24,287
8,820,796
Cooper
Cos.,
Inc.
(The)
.....................................................
62,398
6,330,901
Danaher
Corp.
............................................................
1,253
312,899
Elevance
Health,
Inc.
......................................................
5,239
2,716,631
Eli
Lilly
&
Co.
.............................................................
8,041
6,255,576
Embecta
Corp.
...........................................................
1,399
18,565
Establishment
Labs
Holdings,
Inc.*
...........................................
25,493
1,297,594
Exact
Sciences
Corp*
......................................................
64,027
4,421,705
Fulcrum
Therapeutics,
Inc.*
.................................................
211,031
1,992,133
HCA
Healthcare
Inc
........................................................
1,415
471,945
Henry
Schein,
Inc.*
........................................................
3,520
265,830
Humana,
Inc.
.............................................................
210
72,811
IDEXX
Laboratories,
Inc.*
...................................................
2,819
1,522,063
Insulet
Corp.*
.............................................................
14,979
2,567,401
Intuitive
Surgical,
Inc.*
......................................................
32,348
12,909,763
Johnson
&
Johnson
........................................................
24,295
3,843,226
Leap
Therapeutics,
Inc.*
....................................................
375,976
1,000,096
LivaNova
PLC*
...........................................................
8,613
481,811
Masimo
Corp.*
...........................................................
9,832
1,443,829
Merck
&
Co.,
Inc.
..........................................................
47,663
6,289,133
Natera,
Inc.*
.............................................................
12,669
1,158,707
Regeneron
Pharmaceuticals,
Inc.*
............................................
3,050
2,935,595
Revvity
Inc
...............................................................
25,919
2,721,495
Royalty
Pharma
PLC,
Class
A
...............................................
148,455
4,508,578
Sarepta
Therapeutics
Inc*
...................................................
90,523
11,719,108
Shockwave
Medical,
Inc.*
...................................................
14,945
4,866,540
Stryker
Corp.
.............................................................
5,089
1,821,200
Syndax
Pharmaceuticals,
Inc.*
...............................................
25,337
603,021
Tenet
Healthcare
Corp.*
....................................................
4,713
495,383
Thermo
Fisher
Scientific,
Inc.
................................................
8,271
4,807,188
Ultragenyx
Pharmaceutical
Inc*
..............................................
30,753
1,435,858
UnitedHealth
Group,
Inc.
....................................................
1,900
939,930
Veeva
Systems,
Inc.,
Class
A*
...............................................
1,936
448,552
Zimmer
Biomet
Holdings
Inc
.................................................
25,796
3,404,556
124,240,066
Industrials
–
1.9%
3M
Co
..................................................................
24,530
2,601,897
Veralto
Corp.
.............................................................
388
34,400
2,636,297
Simplify
Health
Care
ETF
Schedule
of
Investments
(Continued)
March
31,
2024
(Unaudited)
2
††
The
percentage
shown
for
each
investment
category
is
the
total
value
of
investments
in
that
category
as
a
percentage
of
the
net
assets
of
the
Fund.
The
table
depicts
the
Fund's
investments
but
may
not
represent
the
Fund's
market
exposure
to
certain
derivatives,
if
any,
which
are
included
in
Other
Assets
in
Excess
of
Liabilities.
Shares
Value
Common
Stocks
(continued)
Materials
–
4.9%
PureCycle
Technologies,
Inc.*
...............................................
1,064,440
$
6,620,817
Total
Common
Stocks
(Cost
$120,797,281)
.........................................
133,497,180
Money
Market
Funds
–
1.9%
Fidelity
Investments
Money
Market
Treasury
Only
Portfolio
-
Class
I,
5.20%(a)
(Cost
$2,590,732)
.......................................................
2,590,732
2,590,732
Total
Investments
–
100.0%
(Cost
$123,388,013)
...........................................................
$
136,087,912
Other
Assets
in
Excess
of
Liabilities
–
0.0%†
..........................................
21,596
Net
Assets
–
100.0%
............................................................
$
136,109,508
*
Non
Income
Producing
†
Less
than
0.05%
(a)
Rate
shown
reflects
the
7-day
yield
as
of
March
31,
2024.
Summary
of
Investment
Type††
Industry
%
of
Net
Assets
Common
Stocks
.................................................................................
98.1%
Money
Market
Funds
.............................................................................
1.9%
Total
Investments
................................................................................
100.0%
Other
Assets
in
Excess
of
Liabilities
..................................................................
0.0%†
Net
Assets
.....................................................................................
100.0%